Our Products
Loans
Cards
Insurance
Investment
Stock Market
Electronics Mall
CIBIL Score
Knowledge Centre
Academy 
Calculators
Our Services
My Account
Do not call
En
Laurus Labs Ltd. Share Price
Day's Range
Day's Range
Low
₹1,811.70
High
₹1,864.40
Price Summary
| Previous Close | ₹1,864.00 |
|---|---|
| Day's Range | ₹1,811.70 - ₹1,864.40 |
| Open | ₹1,853.20 |
| 52 Week Range | ₹823.10 - ₹1,949.00 |
| Volume | 22,65,630 |
| Market Cap | ₹0.10 |
| Previous Close | ₹1,863.00 |
|---|---|
| Day's Range | ₹1,812.00 - ₹1,864.35 |
| Open | ₹1,860.00 |
| 52 Week Range | ₹822.85 - ₹1,947.90 |
| Volume | 33,913 |
| Market Cap | ₹0.10 |
Stocks Summary
| Trade Value ( ₹ in Lacs) | 41,551.62 |
|---|---|
| Market Cap (₹ in Mn) | 0.10 |
| Dividend Yield(%) | 0.11 |
| Price/Earning (TTM) | 92.06 |
| TTM EPS (₹) | 20.24 |
| P/E Ratio | 60.25 |
| Book Value(₹) | 17.85 |
| PAT Margin (%) | 13.06 |
| Face Value (₹) | 2.00 |
| ROCE(%) | 18.20 |
| Trade Value ( ₹ in Lacs) | 623.06 |
|---|---|
| Market Cap (₹ in Mn) | 0.10 |
| Dividend Yield(%) | 0.11 |
| Price/Earning (TTM) | 92.06 |
| TTM EPS (₹) | 20.24 |
| P/E Ratio | 60.25 |
| Book Value(₹) | 17.85 |
| PAT Margin (%) | 13.06 |
| Face Value (₹) | 2.00 |
| ROCE(%) | 18.20 |
Financials
| Particulars | QTR FY (₹ in Millions) | Annual FY (₹ in Millions) |
|---|---|---|
| Net sales | 14327.5 | 55539.6 |
| Expenses | N/A | N/A |
| PBT | 2114.4 | 4882.2 |
| Operating profit | 0.0 | 0.0 |
| Net profit | 1579.4 | 3583.4 |
About Laurus Labs Ltd.
| Founded | 2005 |
|---|---|
| NSE Symbol | LAURUSLABS |
Peer Comparision
| Stocks Name | Market Cap (Cr)(₹) | Market Price (₹) | 52 Week Low-High (₹) |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | 4,63,791.45 | 1,933.00 | 1,548.00 - 1,548.00 |
| Divi's Laboratories Ltd. | 2,45,080.59 | 9,232.00 | 5,636.50 - 5,636.50 |
| Torrent Pharmaceuticals Ltd. | 1,90,351.29 | 5,004.40 | 3,480.60 - 3,480.60 |
| Apollo Hospitals Enterprise Ltd. | 1,25,308.33 | 8,715.00 | 6,696.50 - 6,696.50 |
| Lenskart Solutions Ltd. | 1,16,281.31 | 668.55 | 0.00 - 0.00 |
| Zydus Lifesciences Ltd. | 1,14,832.64 | 1,151.20 | 835.50 - 835.50 |
| Cipla Ltd. | 1,14,162.52 | 1,413.15 | 1,165.70 - 1,165.70 |
| Laurus Labs Ltd. | 1,00,660.17 | 1,863.00 | 823.10 - 823.10 |
| Lupin Ltd. | 98,431.05 | 2,152.60 | 1,875.00 - 1,875.00 |
| Mankind Pharma Ltd. | 98,304.73 | 2,380.00 | 1,909.70 - 1,909.70 |
No Records Found
Latest News
Laurus Labs submits analyst meet intimation
Laurus Labs informs about AGM
Pursuant to Regulation 34 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Laurus Labs has informed that it enclosed the Notice convening the 21st Annual General Meeting (‘AGM’) of shareholders of the Company, scheduled to be held on Thursday, July 2, 2026 at 3.00 pm (IST) through Video Conferencing (‘VC’)/ through Other Audio-Visual Means (‘OAVM’). The Notice of 21st AGM is also available on the Company’s website at www.lauruslabs.com.
The above information is a part of company’s filings submitted to BSE.
GlaxoSmithKline Pharmaceuticals informs about press release
Samrat Pharmachem informs about newspaper publication
Hikal informs about investors meet
Pursuant to the provisions of Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Hikal has informed that Analysts and Institutional Investors (‘Participants’) are scheduled to visit the Company's Pune R&T centre and interact with the Company's officials, as per the details enclosed. Discussions will be based on publicly available information.
The above information is a part of company’s filings submitted to BSE.
No Records Found
Sign in to Unlock Offers!
We don't SPAM
Frequently Asked Questions
The current share price of Laurus Labs Ltd. is ₹1,864.00 as of 2026-09-02.
The market capitalisation of Laurus Labs Ltd. is ₹100,660.17 as of 2026-09-02.
The 1-year return of Laurus Labs Ltd. is 1,003.90% as of 2026-09-02.
The P/E ratio of Laurus Labs Ltd. is 60.25 as of 2026-09-03.
The 52-week high and low of Laurus Labs Ltd. are ₹1,949.00 and ₹823.10, respectively, as of 2026-09-02.
People Also Ask
Laurus Labs Ltd. provides active pharmaceutical ingredients, generic formulations and contract‑development/manufacturing services, with strengths in antivirals, oncology and chronic therapies.
Laurus Labs Ltd. collaborates via API and formulation supply agreements and CDMO partnerships with global generic and branded pharma companies that serve hospitals worldwide.
Disclaimer
All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.
The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.
Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform.
